Lanean...
The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma
The proteasome has been validated as an anticancer drug target, while the role of a subunit of proteasome, PSMC6, in lung adenocarcinoma (LUAD) has not been fully unveiled. In this study, we observed that both the RNA and protein of PSMC6 were highly upregulated in LUAD compared with the adjacent no...
Gorde:
| Argitaratua izan da: | Biomed Res Int |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235974/ https://ncbi.nlm.nih.gov/pubmed/34239933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9922185 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|